Archives
-
gamma-Glu-Cys (γ-Glu-Cys): Lab Workflow Guide
2026-09-03
gamma-Glu-Cys (γ-Glu-Cys) provides a defined L-glutathione biosynthesis intermediate for glutathione synthetase enzyme assay development, glutathione metabolism research, and related peptide workflows. It is intended for controlled scientific research use only and should not be used for diagnostic, therapeutic, or medical applications.
-
RNA Pol II Inhibition and Active Cell Death Signaling
2026-09-03
Harper et al. show that RNA Pol II inhibition kills cells through an active apoptotic pathway triggered by loss of hypophosphorylated RNA Pol IIA, rather than through transcriptional collapse alone. Their functional-genomics framework identifies a Pol II degradation-dependent apoptotic response that can also explain the lethality of therapeutics with apparently unrelated mechanisms.
-
Piezo1, Matrix Stiffness, and DRG Axon Regeneration
2026-09-02
The reference study shows that extracellular matrix stiffness regulates dorsal root ganglion axon regrowth through a Piezo1-dependent Ca2+–CaMKII–FAK–actin pathway. Its most important practical implication is that both mechanical stiffness and mechanosensitive signaling may need to be tuned, because excessive Piezo1 activity can restrain regeneration whereas Piezo1 knockdown improved recovery after sciatic nerve injury.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-09-02
Build cleaner CRISPR-Cas9 genome editing workflows with a Cap1-capped, m1Ψ-modified Cas9 transcript designed for efficient translation and reduced innate immune stimulation. This practical guide connects product handling, mammalian-cell assay design, and the reference study’s mRNA-export findings to help separate delivery limits from editing biology.
-
Tetrahydromagnolol: Peripheral CB2 Agonist
2026-09-01
Tetrahydromagnolol is a selective peripheral CB2 receptor agonist and a GPR55 antagonist for cannabinoid receptor research. Its reported CB2 and GPR55 pharmacology supports controlled studies of cannabinoid signaling, inflammation, and analgesic mechanisms, but it does not establish a clinical or anti-metastatic use.
-
Arachidonic Acid Supplementation Boosts Humoral Immunity
2026-09-01
Feng and colleagues report that dietary arachidonic acid enhances rabies vaccine-induced neutralizing antibodies and protection in mice, while accelerating protective antibody development in human volunteers. The study links this effect to lymph-node lipid metabolism, prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells, providing a mechanistic framework for dietary support of germinal-center responses.
-
Patient-Derived Gastric Cancer Assembloids
2026-08-31
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids by combining tumor organoids with matched stromal subpopulations from the same specimen. The model reproduced clinically relevant tumor–stroma interactions and showed that stromal composition can alter transcriptional states and drug sensitivity, supporting more context-aware preclinical testing.
-
PP2A, Autophagy, and Candida Biofilm Resistance
2026-08-31
The reference study identifies PP2A-dependent autophagy as a regulatory pathway connecting Atg13 and Atg1 phosphorylation with Candida albicans biofilm formation and antifungal drug resistance. Genetic disruption of PPH21 weakened this response and improved antifungal efficacy in an oral infection model, providing a mechanistic framework for studying biofilm persistence.
-
Phenytoin Beyond Sodium Channels: Assay Strategy
2026-08-30
Phenytoin is more than a sodium-channel research reagent: it can also serve as a useful probe for separating electrophysiological effects from biochemical enzyme interactions. This guide integrates product handling, PON1 inhibition data, and assay-design decisions for rigorous neurological research.
-
AZD1480: A Translational Compass for JAK2/STAT3
2026-08-29
AZD1480 offers a precise way to test whether tumor-intrinsic JAK2/STAT3 signaling enables cancer cells to survive immune-metabolic pressure. This thought-leadership guide connects its ATP-competitive pharmacology with biomarker strategy, model selection, combination design, and the limitations that matter for translational oncology.
-
SU5416 Workflow for Angiogenesis Research
2026-08-28
SU5416 (Semaxanib) enables mechanism-focused studies of VEGFR2 signaling, endothelial angiogenesis, tumor vascularization, and selected immune effects. This practical guide connects concentration-response assays with pulmonary vascular modeling, emphasizing formulation control, orthogonal readouts, and troubleshooting.
-
Bergenin Targets γδT17 Cells in Psoriasis
2026-08-28
A 2026 Phytomedicine study identifies a PPARγ–PROX1–fatty acid oxidation pathway through which bergenin suppresses pathogenic γδT17 cells and reduces psoriasiform inflammation. Its combination of animal modeling, metabolic analysis, protein-interaction assays, and chromatin measurements provides a mechanistic framework for evaluating selective IL-17A regulation in psoriasis.
-
DMG-PEG2000-NH2: From Linker to Assay Design
2026-08-27
DMG-PEG2000-NH2 is an NH2-PEG derivative for rational bioconjugation and lipid nanoparticle workflows. This article goes beyond formulation basics to connect linker chemistry, analytical controls, and the assay-design lessons of optimized sulfonamide research.
-
Trypsin for Protease-Controlled Cell Biology
2026-08-27
Trypsin is a serine protease whose value extends beyond routine protein digestion. This article explains how to use its cleavage specificity as an experimental control while connecting protease handling to cell biology, cartilage assay design, viral membrane fusion, wound healing research, and neurogenic inflammation study.
-
Biotin-tyramide (A8011): TSA Workflow Guide
2026-08-26
Biotin-tyramide is a biotinylation reagent for HRP-driven tyramide signal amplification when conventional IHC or ISH signals are too weak or poorly localized. This guide covers solvent handling, assay setup, controls, and troubleshooting for fixed-cell and tissue workflows; it is for research use only and not for diagnostic, medical, or unvalidated live-cell applications.